S. Brouard, A. Pallier, K. Renaudin, Y. Foucher, R. Danger et al., The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases, Am J Transplant, vol.12, pp.3296-3307, 2012.

G. Orlando, P. Hematti, R. J. Stratta, G. W. Burke, D. Cocco et al., Clinical operational tolerance after renal transplantation: Current status and future challenges, Ann Surg, vol.252, pp.915-928, 2010.
DOI : 10.1097/sla.0b013e3181f3efb0
URL : http://europepmc.org/articles/pmc4547843?pdf=render

G. Roussey-kesler, M. Giral, A. Moreau, J. F. Subra, C. Legendre et al., Clinical operational tolerance after kidney transplantation, Am J Transplant, vol.6, pp.736-746, 2006.
DOI : 10.1111/j.1600-6143.2006.01280.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2006.01280.x

S. Louis, C. Braudeau, M. Giral, A. Dupont, F. Moizant et al., Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance, Transplantation, vol.81, pp.398-407, 2006.
DOI : 10.1097/01.tp.0000203166.44968.86

A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racapé et al., Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, pp.503-513, 2010.

S. Brouard, E. Mansfield, C. Braud, L. Li, M. Giral et al., Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci U S A, vol.104, pp.15448-15453, 2007.

K. A. Newell, A. Asare, A. D. Kirk, T. D. Gisler, K. Bourcier et al., Seyfert-Margolis VL; Immune Tolerance Network ST507 Study Group: Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1836-1847, 2010.

P. Sagoo, E. Perucha, B. Sawitzki, S. Tomiuk, D. A. Stephens et al., Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1848-1861, 2010.

C. Braudeau, M. Racape, M. Giral, S. Louis, A. Moreau et al., Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome, Transpl Int, vol.20, pp.845-855, 2007.

P. M. Moraes-vieira, M. C. Takenaka, H. M. Silva, S. M. Monteiro, F. Agena et al., GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation, Clin Immunol, vol.142, pp.117-126, 2012.

P. M. Moraes-vieira, H. M. Silva, M. C. Takenaka, S. M. Monteiro, F. Lemos et al., Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals, vol.71, pp.442-450, 2010.

C. Y. Lin, L. Graca, S. P. Cobbold, and H. Waldmann, Dominant transplantation tolerance impairs CD8+ T cell function but not expansion, Nat Immunol, vol.3, pp.1208-1213, 2002.
DOI : 10.1038/ni853

H. Waldmann, L. Graca, S. Cobbold, A. E. Tone, M. Tone et al., Regulatory T cells and organ transplantation, Semin Immunol, vol.16, pp.119-126, 2004.

L. Graca, S. P. Cobbold, and H. Waldmann, Identification of regulatory T cells in tolerated allografts, J Exp Med, vol.195, pp.1641-1646, 2002.

J. A. Hill, M. Feuerer, K. Tash, S. Haxhinasto, J. Perez et al., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature, Immunity, vol.27, pp.786-800, 2007.

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009.

, J Am Soc Nephrol, vol.26, pp.1795-1805, 2015.

, Tregs in Transplantation Tolerance

M. A. Gavin, J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello et al., Foxp3-dependent programme of regulatory T-cell differentiation, Nature, vol.445, pp.771-775, 2007.

N. Ohkura, Y. Kitagawa, and S. Sakaguchi, Development and maintenance of regulatory T cells, Immunity, vol.38, pp.414-423, 2013.

H. Morikawa, N. Ohkura, A. Vandenbon, M. Itoh, S. Nagao-sato et al., Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation, Proc Natl Acad Sci U S A, vol.111, pp.5289-5294, 2014.

J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe et al., DNA methylation controls Foxp3 gene expression, Eur J Immunol, vol.38, pp.1654-1663, 2008.

Y. Zheng, S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush et al., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate, Nature, vol.463, pp.808-812, 2010.

A. Toker, D. Engelbert, G. Garg, J. K. Polansky, S. Floess et al., Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus, J Immunol, vol.190, pp.3180-3188, 2013.

N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka et al., T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development, Immunity, vol.37, pp.785-799, 2012.

L. C. Racusen, K. Solez, R. B. Colvin, S. M. Bonsib, M. C. Castro et al., The Banff 97 working classification of renal allograft pathology, Kidney Int, vol.55, pp.713-723, 1999.

M. Haas, B. Sis, L. C. Racusen, K. Solez, D. Glotz et al., Mengel M; Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, pp.272-283, 2014.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, vol.203, pp.1701-1711, 2006.

M. Vukmanovic-stejic, Y. Zhang, J. E. Cook, J. M. Fletcher, A. Mcquaid et al., Akbar AN: Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo, J Clin Invest, vol.116, pp.2423-2433, 2006.

D. Valmori, A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub, A peripheral circulating compartment of natural naive CD4 Tregs, J Clin Invest, vol.115, pp.1953-1962, 2005.

C. Schmidl, L. Hansmann, T. Lassmann, P. J. Balwierz, H. Kawaji et al., The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations, Blood, vol.123, pp.68-78, 2014.

C. Braud, D. Baeten, M. Giral, A. Pallier, J. Ashton-chess et al., Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis, J Cell Biochem, vol.103, pp.1681-1692, 2008.

F. Braza, J. P. Soulillou, and S. Brouard, Gene expression signature in transplantation tolerance, Clin Chim Acta, vol.413, pp.1414-1418, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02167912

J. Dantal and J. P. Soulillou, Immunosuppressive drugs and the risk of cancer after organ transplantation, N Engl J Med, vol.352, pp.1371-1373, 2005.

M. Chesneau, L. Michel, N. Degauque, and S. Brouard, Regulatory B cells and tolerance in transplantation: from animal models to human, Front Immunol, vol.4, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165775

M. Schaier, N. Seissler, E. Schmitt, S. Meuer, F. Hug et al., DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients, PLoS ONE, vol.7, p.34208, 2012.

L. E. Becker, F. De-oliveira-biazotto, H. Conrad, M. Schaier, L. P. Kihm et al., Cellular infiltrates and NFkB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance, Transplantation, vol.94, pp.729-737, 2012.

J. Zuber, A. Brodin-sartorius, N. Lapidus, N. Patey, M. Tosolini et al., FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis, Nephrol Dial Transplant, vol.24, pp.3847-3854, 2009.

C. L. Bennett, J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, vol.27, pp.20-21, 2001.

S. Hori, T. Nomura, and S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3, Science, vol.299, pp.1057-1061, 2003.

J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat Immunol, vol.4, pp.330-336, 2003.

S. E. Allan, S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production, Int Immunol, vol.19, pp.345-354, 2007.

O. Bestard, L. Cuñetti, J. M. Cruzado, M. Lucia, R. Valdez et al., Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome, Am J Transplant, vol.11, pp.2162-2172, 2011.

N. Seddiki, B. Santner-nanan, S. G. Tangye, S. I. Alexander, M. Solomon et al., Fazekas de Saint Groth B: Persistence of naive CD45RA+ regulatory T cells in adult life, Blood, vol.107, pp.2830-2838, 2006.

T. Akimova, B. M. Kamath, J. W. Goebel, K. E. Meyers, E. B. Rand et al., Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients, Am J Transplant, vol.12, pp.3449-3461, 2012.

K. J. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nat Rev Immunol, vol.12, pp.417-430, 2012.

D. Ianni, M. Falzetti, F. Carotti, A. Terenzi, A. Castellino et al., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, vol.117, pp.3921-3928, 2011.

L. Antonioli, P. Pacher, E. S. Vizi, and G. Haskó, CD39 and CD73 in immunity and inflammation, Trends Mol Med, vol.19, pp.355-367, 2013.

S. Crikis, B. Lu, L. M. Murray-segal, C. Selan, S. C. Robson et al., Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury, Am J Transplant, vol.10, pp.2586-2595, 2010.

S. Deaglio, K. M. Dwyer, W. Gao, D. Friedman, A. Usheva et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J Exp Med, vol.204, pp.1257-1265, 2007.

G. Borsellino, M. Kleinewietfeld, D. Mitri, D. Sternjak, A. Diamantini et al., Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression, Blood, vol.110, pp.1225-1232, 2007.

W. Chen, J. W. Hardegen, N. Lei, K. J. Li, L. Marinos et al., Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, vol.198, pp.1875-1886, 2003.

L. D. Haynes, E. Jankowska-gan, A. Sheka, M. R. Keller, M. P. Hernandezfuentes et al., Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients, Am J Transplant, vol.12, pp.640-648, 2012.

E. C. Rosser, P. A. Blair, and C. Mauri, Cellular targets of regulatory B cell-mediated suppression, Mol Immunol, vol.62, pp.296-304, 2014.

G. Wieczorek, A. Asemissen, F. Model, I. Turbachova, S. Floess et al., Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue, Cancer Res, vol.69, pp.599-608, 2009.